Navigation Links
Special One-Day Rates Available For DIA 45th Annual Meeting June 21-25 in San Diego
Date:6/16/2009

The 45th Annual Meeting provides access to more than 350 sessions focusing on issues in global drug discovery and development, three megatracks in IT, clinical research, and advertising/marketing/medical communications, and the industry's largest interactive exhibit hall.

Horsham, PA, USA (Vocus) June 16, 2009 -- The Drug Information Association (DIA) offers special one-day rates to attend the 45th Annual Meeting (June 21-25; San Diego, CA).

The 45th Annual Meeting provides access to more than 350 sessions focusing on issues in global drug discovery and development, three megatracks in IT, clinical research, and advertising/marketing/medical communications, and the industry's largest interactive exhibit hall.

FEATURED SESSIONS

 
  • Monday's multi-track plenary session, Improving Safety with Every Step: Pillars of the Pharmaceutical Landscape
  • Current event sessions
  • Hot topics! Phase 1 Early Development, Accelerated Development Time, US FDA Sentinel Initiative, Transparency, Pharmacogenomics and Personalized Medicines and much more!
  • Pharma in the New Age of Transparency
  • Meet the Regulators
  • CDER Town Meeting Parts 1 and 2
  • European Medicines Agency Town Hall

One-day registrants have access to all preconference PowerPoint presentations of sessions that occur the day for which they are registered. Preconference presentations are available online until 12:00PM PST, Thursday, June 25. In addition, one-day registrants receive access to audio-synchronized PowerPoint presentations through DIA's Live Learning Center (LLC) following the 45th Annual Meeting.

The 45th Annual Meeting is the biopharmaceutical industry's largest and longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug discovery and development, including two timely sessions reflecting the state of today's global biopharmaceutical environment.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.

Contact:
Joe Krasowski
+1-215-293-5812

Bonnie Shaw
Clearpoint Agency, Inc.
+1-858-724-2500

# # #

Read the full story at http://www.prweb.com/releases/DIA/45th_Annual_Meeting/prweb2541804.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Kevin Niksarli, M.D. of Manhattan Lasik Center is to Discuss the iLASIK Procedure on AMWC Subspecialty Day Meeting on 7/1/2009
2. LASIK Specialist Board Certified Eye Surgeon Dr. Kevin Niksarli, M.D. of Manhattan Lasik Center Announces Website Update
3. Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners
4. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
5. Forterus Inc. Announces Special Board Meeting; Nominates Jeff Walton, Former Bear Stearns President, to Board of Directors
6. Masimo Debuts New Rad-8(R) Pulse Oximeter to Largest Gathering of Sleep Specialists From Around the World at SLEEP 2009
7. 2009 Special Olympics Minnesota Summer Games
8. Schneider Introduces APO-Xenoplan 2.0/24mm Lens, Specially Designed for Kodak 4 MP Sensors Having Microlenses
9. Genaera Corporation Announces Results of Special Meeting of Stockholders
10. Low T Specialist, reNEW MAN Promotes National Network of Doctors
11. Special Ed Services Lacking for Kids Who Repeat a Grade
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Special One-Day Rates Available For DIA 45th Annual Meeting June 21-25 in San Diego 
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology: